David Brookes - CardieX Independent Non-Executive Director

Director

Dr. David L. Brookes serves as Independent NonExecutive Director of AtCor Medical Holdings Limited. He was appointed on November 2008. He is the Independent director for the Group since November 2008. he is a Fellow of the Australian College of Rural and Remote Medicine. He currently works as a general medical practitioner and has extensive experience in rural Australia, especially in paediatric and procedural practice. since 2008.
Tenure 16 years
Professional MarksPh.D
Phone61 2 9874 8761
Webhttp://cardiex.com

CardieX Management Efficiency

The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.97) %, meaning that it generated substantial loss on money invested by shareholders. CardieX's management efficiency ratios could be used to measure how well CardieX manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. CardieX Limited has a current ratio of 1.67, which is within standard range for the sector. Debt can assist CardieX until it has trouble settling it off, either with new capital or with free cash flow. So, CardieX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardieX Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardieX to invest in growth at high rates of return. When we think about CardieX's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Rodrigo PinaTernium SA ADR
51
Ralph RattaOlympic Steel
64
Christopher AyersUniversal Stainless Alloy
51
Gianfelice RoccaTernium SA ADR
71
Christy ClarkConstellation Brands Class
54
Howard GoldsteinOlympic Steel
65
David KornblattUniversal Stainless Alloy
58
Kazuhiro KoshikawaNippon Steel Corp
N/A
Michael RippeyOlympic Steel
60
Hidetake IshiharaNippon Steel Corp
N/A
James LockeConstellation Brands Class
78
Mutsutake OhtsukaNippon Steel Corp
75
Kazuhiro NakashimaNippon Steel Corp
N/A
Keith WandellConstellation Brands Class
69
Nobuhiro FujitaNippon Steel Corp
N/A
Judy SchmelingConstellation Brands Class
60
Roberto BonattiTernium SA ADR
70
Takashi HiroseNippon Steel Corp
N/A
Ubaldo AguirreTernium SA ADR
71
Toru TakegoshiNippon Steel Corp
N/A
Bruno MarchettiniTernium SA ADR
71
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia. Cardiex is traded on OTC Exchange in the United States. CardieX Limited [AMDHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

CardieX Limited Leadership Team

Elected by the shareholders, the CardieX's board of directors comprises two types of representatives: CardieX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardieX. The board's role is to monitor CardieX's management team and ensure that shareholders' interests are well served. CardieX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardieX's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rhonda Welch, Vice President of Global Marketing
David Brookes, Independent Non-Executive Director
Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd
Niall Cairns, Non-Executive Director
Chris Dax, Vice President - Operations
Peter Jenkins, Independent Non-Executive Director
Craig Cooper, CEO, Executive Director
Duncan Ross, CEO, Managing Director, Executive Director
Randall Nelson, Independent Non-Executive Director
Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc
Michael ORourke, Non-Executive Director
Donal ODwyer, Independent Non-Executive Chairman of the Board
Peter Manley, CFO, Company Secretary

CardieX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CardieX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CardieX

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CardieX position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CardieX will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Fossil could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fossil when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fossil - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fossil Group to buy it.
The correlation of Fossil is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fossil moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fossil Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fossil can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in CardieX OTC Stock

If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities